biote Corp. (BTMD) intrinsic value & 10-year financials
biote Corp. (BTMD) has a Graham intrinsic value of $16.10 per share. At $1.09 on Oct 17, 2026, the stock trades 93% below that value. Over the last 6 fiscal years revenue grew 8.4% a year to $192.2M, with an average return on invested capital of -427.4%.
- Graham intrinsic value
- $16.10
- Share price (Oct 17, 2026)
- $1.09
- Price vs Graham value
- 93% below
- Market cap
- $39.8M
- Revenue (FY2025)
- $192.2M
- Revenue growth (6-yr CAGR)
- 8.4%
- ROIC (10-yr avg)
- -427.4%
- Free cash flow (FY2025)
- $30.2M
BTMD 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $192.2M | $27.0M | $0.74 | $30.2M | 18.5% | -438.9% |
| FY2024 | $197.2M | $3.2M | $0.09 | $38.8M | 16.0% | -124.7% |
| FY2023 | $185.4M | $3.3M | $0.13 | $26.5M | 15.5% | -436.1% |
| FY2022 | $165.0M | -$969.0K | -$0.12 | -$9.5M | -36.8% | -1113.9% |
| FY2021 | $139.4M | $11.1M | — | -$2.8M | -2.4% | -23.2% |
| FY2020 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
biote Corp. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
biote Corp. has historically struggled to out-earn its cost of capital, averaging just -33.6% ROIC.
biote Corp. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, biote Corp. is modeled at 8.4% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $16.10 per share.